

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of other organism (GO:0098543) | 4.79899874 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.59229729 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.59229729 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.54061993 |
| 5 | detection of bacterium (GO:0016045) | 4.53368405 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.28683541 |
| 7 | detection of external biotic stimulus (GO:0098581) | 4.15983038 |
| 8 | detection of molecule of bacterial origin (GO:0032490) | 4.15525592 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.02450974 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.79674481 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 3.78445988 |
| 12 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.72208141 |
| 13 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.68220950 |
| 14 | detection of biotic stimulus (GO:0009595) | 3.66987595 |
| 15 | neutrophil activation (GO:0042119) | 3.58860387 |
| 16 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.55549075 |
| 17 | response to host immune response (GO:0052572) | 3.55549075 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.49523308 |
| 19 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.48109751 |
| 20 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.46220196 |
| 21 | negative regulation of phagocytosis (GO:0050765) | 3.45850629 |
| 22 | regulation of mast cell degranulation (GO:0043304) | 3.44438945 |
| 23 | macrophage activation (GO:0042116) | 3.41501914 |
| 24 | positive thymic T cell selection (GO:0045059) | 3.40073536 |
| 25 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.40072073 |
| 26 | negative regulation of cell killing (GO:0031342) | 3.40072073 |
| 27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.36086640 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.36086640 |
| 29 | modulation by symbiont of host immune response (GO:0052553) | 3.36086640 |
| 30 | positive regulation by symbiont of host defense response (GO:0052509) | 3.36086640 |
| 31 | modulation by symbiont of host defense response (GO:0052031) | 3.36086640 |
| 32 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.36086640 |
| 33 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.35944223 |
| 34 | respiratory burst (GO:0045730) | 3.33363656 |
| 35 | granulocyte activation (GO:0036230) | 3.32106318 |
| 36 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.29002775 |
| 37 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.27872579 |
| 38 | myeloid cell activation involved in immune response (GO:0002275) | 3.27515360 |
| 39 | negative regulation of T cell mediated immunity (GO:0002710) | 3.27272713 |
| 40 | regulation of leukocyte degranulation (GO:0043300) | 3.26915993 |
| 41 | microglial cell activation (GO:0001774) | 3.26015970 |
| 42 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.23256386 |
| 43 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.22668397 |
| 44 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.21753558 |
| 45 | positive regulation of histone deacetylation (GO:0031065) | 3.19655801 |
| 46 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.13139666 |
| 47 | germinal center formation (GO:0002467) | 3.12942243 |
| 48 | positive regulation of B cell differentiation (GO:0045579) | 3.07782286 |
| 49 | positive regulation of mast cell activation (GO:0033005) | 3.06894793 |
| 50 | cellular extravasation (GO:0045123) | 3.06248812 |
| 51 | negative regulation of granulocyte differentiation (GO:0030853) | 3.03171063 |
| 52 | neutrophil mediated immunity (GO:0002446) | 3.01988229 |
| 53 | response to muramyl dipeptide (GO:0032495) | 3.01840882 |
| 54 | cellular response to interleukin-15 (GO:0071350) | 3.00426415 |
| 55 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.93665600 |
| 56 | response to laminar fluid shear stress (GO:0034616) | 2.93144389 |
| 57 | macrophage activation involved in immune response (GO:0002281) | 2.90252651 |
| 58 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.90242522 |
| 59 | morphogenesis of an endothelium (GO:0003159) | 2.88555809 |
| 60 | endothelial tube morphogenesis (GO:0061154) | 2.88555809 |
| 61 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.88006633 |
| 62 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.86572901 |
| 63 | regulation of mast cell activation (GO:0033003) | 2.85252472 |
| 64 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.85165442 |
| 65 | response to type I interferon (GO:0034340) | 2.83611413 |
| 66 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.83412227 |
| 67 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.83340348 |
| 68 | cellular response to type I interferon (GO:0071357) | 2.83249585 |
| 69 | type I interferon signaling pathway (GO:0060337) | 2.83249585 |
| 70 | B cell receptor signaling pathway (GO:0050853) | 2.82216985 |
| 71 | negative regulation of interleukin-12 production (GO:0032695) | 2.81358453 |
| 72 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.80914110 |
| 73 | negative regulation of innate immune response (GO:0045824) | 2.79906554 |
| 74 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.78617606 |
| 75 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.77294005 |
| 76 | regulation of regulated secretory pathway (GO:1903305) | 2.73215683 |
| 77 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.72030763 |
| 78 | regulation of B cell differentiation (GO:0045577) | 2.71341554 |
| 79 | defense response to protozoan (GO:0042832) | 2.71196961 |
| 80 | regulation of necroptotic process (GO:0060544) | 2.70250941 |
| 81 | thymic T cell selection (GO:0045061) | 2.69962613 |
| 82 | angiogenesis involved in wound healing (GO:0060055) | 2.68606459 |
| 83 | NIK/NF-kappaB signaling (GO:0038061) | 2.67887326 |
| 84 | positive regulation of interferon-alpha production (GO:0032727) | 2.67263883 |
| 85 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.66453750 |
| 86 | negative regulation of type 2 immune response (GO:0002829) | 2.66178683 |
| 87 | leukocyte degranulation (GO:0043299) | 2.65978528 |
| 88 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.64753195 |
| 89 | regulation of macrophage cytokine production (GO:0010935) | 2.63537608 |
| 90 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.62992862 |
| 91 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.62039099 |
| 92 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.62039099 |
| 93 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.60732944 |
| 94 | response to fluid shear stress (GO:0034405) | 2.60675765 |
| 95 | definitive hemopoiesis (GO:0060216) | 2.60276277 |
| 96 | apoptotic cell clearance (GO:0043277) | 2.59028790 |
| 97 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.58876281 |
| 98 | mannose metabolic process (GO:0006013) | 2.57454435 |
| 99 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.57189274 |
| 100 | response to peptidoglycan (GO:0032494) | 2.54459144 |
| 101 | germ cell migration (GO:0008354) | 2.54419449 |
| 102 | negative thymic T cell selection (GO:0045060) | 2.54131983 |
| 103 | pre-miRNA processing (GO:0031054) | 2.53430547 |
| 104 | negative regulation of stress fiber assembly (GO:0051497) | 2.52299804 |
| 105 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.51822069 |
| 106 | positive regulation of tolerance induction (GO:0002645) | 2.51128326 |
| 107 | pinocytosis (GO:0006907) | 2.49959402 |
| 108 | regulation of interferon-alpha production (GO:0032647) | 2.49356620 |
| 109 | growth hormone receptor signaling pathway (GO:0060396) | 2.48545483 |
| 110 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.48537442 |
| 111 | positive T cell selection (GO:0043368) | 2.48014757 |
| 112 | protein localization to endosome (GO:0036010) | 2.47070062 |
| 113 | negative T cell selection (GO:0043383) | 2.46288218 |
| 114 | immunoglobulin mediated immune response (GO:0016064) | 2.45968941 |
| 115 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.45032596 |
| 116 | nodal signaling pathway (GO:0038092) | 2.44278256 |
| 117 | natural killer cell differentiation (GO:0001779) | 2.43901322 |
| 118 | cell adhesion mediated by integrin (GO:0033627) | 2.43577653 |
| 119 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.42960826 |
| 120 | leukocyte aggregation (GO:0070486) | 2.41012391 |
| 121 | histone H2A monoubiquitination (GO:0035518) | 2.40525727 |
| 122 | positive regulation of protein deacetylation (GO:0090312) | 2.40201693 |
| 123 | T cell selection (GO:0045058) | 2.35710456 |
| 124 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.32981004 |
| 125 | positive regulation of antigen processing and presentation (GO:0002579) | 2.32793296 |
| 126 | regulation of integrin activation (GO:0033623) | 2.31868513 |
| 127 | endodermal cell differentiation (GO:0035987) | 2.31019188 |
| 128 | negative regulation of bone resorption (GO:0045779) | 2.30563270 |
| 129 | endothelial cell chemotaxis (GO:0035767) | 2.30526294 |
| 130 | response to host (GO:0075136) | 2.29956649 |
| 131 | response to host defenses (GO:0052200) | 2.29956649 |
| 132 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.29956649 |
| 133 | tolerance induction (GO:0002507) | 2.29335926 |
| 134 | substrate-dependent cell migration (GO:0006929) | 2.28585181 |
| 135 | regulation of T cell tolerance induction (GO:0002664) | 2.27547157 |
| 136 | blood vessel maturation (GO:0001955) | 2.27286919 |
| 137 | positive regulation of interferon-beta production (GO:0032728) | 2.26772771 |
| 138 | I-kappaB phosphorylation (GO:0007252) | 2.26605650 |
| 139 | regulation of tolerance induction (GO:0002643) | 2.26596947 |
| 140 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.26510768 |
| 141 | positive regulation of lamellipodium assembly (GO:0010592) | 2.26227537 |
| 142 | cortical actin cytoskeleton organization (GO:0030866) | 2.26054169 |
| 143 | neutrophil activation involved in immune response (GO:0002283) | 2.24738274 |
| 144 | establishment of endothelial barrier (GO:0061028) | 2.24100961 |
| 145 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.23846145 |
| 146 | negative regulation of interleukin-6 production (GO:0032715) | 2.23414172 |
| 147 | response to interleukin-15 (GO:0070672) | 2.23291385 |
| 148 | regulation of response to interferon-gamma (GO:0060330) | 2.23207395 |
| 149 | cellular response to zinc ion (GO:0071294) | 2.22885565 |
| 150 | nuclear pore complex assembly (GO:0051292) | 2.22145283 |
| 151 | leukocyte cell-cell adhesion (GO:0007159) | 2.21394478 |
| 152 | negative regulation of fatty acid transport (GO:2000192) | 2.20983986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.16866166 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.90903634 |
| 3 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.83587891 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.58123362 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.53908092 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 3.18325240 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.97310635 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.78765804 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.63020712 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.58880853 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.50169444 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.43982202 |
| 13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.40068188 |
| 14 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.36032605 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.35753992 |
| 16 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.31891047 |
| 17 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.27255106 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.18829321 |
| 19 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.15403388 |
| 20 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.10130307 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.06343498 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.04217545 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.98984920 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.95573169 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.95484854 |
| 26 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.93236693 |
| 27 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.92785875 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 1.91119802 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 1.90602344 |
| 30 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.89358817 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.86244751 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.86205313 |
| 33 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.84823193 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.84247908 |
| 35 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.81216105 |
| 36 | MYB_26560356_Chip-Seq_TH1_Human | 1.81001045 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.79445007 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.76438072 |
| 39 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.75393249 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.68414088 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.67312303 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66606703 |
| 43 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.65826138 |
| 44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.63877936 |
| 45 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.62462175 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.57272850 |
| 47 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.57078448 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54735436 |
| 49 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.54515144 |
| 50 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.51571049 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.51010592 |
| 52 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49696151 |
| 53 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42466958 |
| 54 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.39847723 |
| 55 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37546759 |
| 56 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.36234855 |
| 57 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36038453 |
| 58 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.34500019 |
| 59 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33924595 |
| 60 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30171922 |
| 61 | MAF_26560356_Chip-Seq_TH2_Human | 1.29967482 |
| 62 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28993048 |
| 63 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28460408 |
| 64 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27920800 |
| 65 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.27418195 |
| 66 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.25281102 |
| 67 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23897139 |
| 68 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22260124 |
| 69 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21273414 |
| 70 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.18897126 |
| 71 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17885180 |
| 72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17468824 |
| 73 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.16998289 |
| 74 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.16113384 |
| 75 | GATA1_22025678_ChIP-Seq_K562_Human | 1.14931879 |
| 76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14155786 |
| 77 | KDM2B_26808549_Chip-Seq_K562_Human | 1.13636835 |
| 78 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13631652 |
| 79 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13604290 |
| 80 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12328604 |
| 81 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11926279 |
| 82 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.11007239 |
| 83 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10430035 |
| 84 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.09376765 |
| 85 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09095366 |
| 86 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08030031 |
| 87 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07487040 |
| 88 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06996670 |
| 89 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.06904124 |
| 90 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.06185005 |
| 91 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06176185 |
| 92 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05122776 |
| 93 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.04933900 |
| 94 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.04632373 |
| 95 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.04258834 |
| 96 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03712687 |
| 97 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02716727 |
| 98 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02671147 |
| 99 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01824743 |
| 100 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01348018 |
| 101 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01135848 |
| 102 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01079742 |
| 103 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.00965311 |
| 104 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00944595 |
| 105 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99110467 |
| 106 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.98900436 |
| 107 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.98900436 |
| 108 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98827243 |
| 109 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.97672395 |
| 110 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.97094010 |
| 111 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.96589991 |
| 112 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.96589991 |
| 113 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95754918 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95134297 |
| 115 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94334537 |
| 116 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.92503419 |
| 117 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.91870115 |
| 118 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.91538256 |
| 119 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.90804882 |
| 120 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.88507492 |
| 121 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.88372773 |
| 122 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88365781 |
| 123 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88343466 |
| 124 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.87828274 |
| 125 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.87492856 |
| 126 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.86676840 |
| 127 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.84354414 |
| 128 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84242723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009278_abnormal_bone_marrow | 2.87135240 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 2.65733458 |
| 3 | MP0003303_peritoneal_inflammation | 2.58241176 |
| 4 | MP0004510_myositis | 2.52256275 |
| 5 | MP0003300_gastrointestinal_ulcer | 2.36948299 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.28965072 |
| 7 | MP0008260_abnormal_autophagy | 2.22628124 |
| 8 | MP0000685_abnormal_immune_system | 2.18326998 |
| 9 | MP0004808_abnormal_hematopoietic_stem | 2.17693667 |
| 10 | MP0003436_decreased_susceptibility_to | 2.17270999 |
| 11 | MP0008438_abnormal_cutaneous_collagen | 2.14487244 |
| 12 | MP0003566_abnormal_cell_adhesion | 2.13174696 |
| 13 | MP0002396_abnormal_hematopoietic_system | 2.10543404 |
| 14 | MP0010352_gastrointestinal_tract_polyps | 2.05001904 |
| 15 | MP0005451_abnormal_body_composition | 1.96973319 |
| 16 | MP0002166_altered_tumor_susceptibility | 1.96436674 |
| 17 | MP0001800_abnormal_humoral_immune | 1.86277035 |
| 18 | MP0003828_pulmonary_edema | 1.80695921 |
| 19 | MP0002452_abnormal_antigen_presenting | 1.77360992 |
| 20 | MP0001545_abnormal_hematopoietic_system | 1.71268502 |
| 21 | MP0005397_hematopoietic_system_phenotyp | 1.71268502 |
| 22 | MP0001790_abnormal_immune_system | 1.69470878 |
| 23 | MP0005387_immune_system_phenotype | 1.69470878 |
| 24 | MP0005076_abnormal_cell_differentiation | 1.68703865 |
| 25 | MP0002419_abnormal_innate_immunity | 1.66924046 |
| 26 | MP0003279_aneurysm | 1.63813407 |
| 27 | MP0005058_abnormal_lysosome_morphology | 1.61175341 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.59708168 |
| 29 | * MP0002420_abnormal_adaptive_immunity | 1.56852528 |
| 30 | MP0002132_abnormal_respiratory_system | 1.56557694 |
| 31 | * MP0001819_abnormal_immune_cell | 1.56551719 |
| 32 | MP0004381_abnormal_hair_follicle | 1.55889148 |
| 33 | * MP0002723_abnormal_immune_serum | 1.54372703 |
| 34 | * MP0002398_abnormal_bone_marrow | 1.51484169 |
| 35 | MP0001873_stomach_inflammation | 1.50112870 |
| 36 | MP0002405_respiratory_system_inflammati | 1.49516449 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.49147043 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.49054165 |
| 39 | MP0005023_abnormal_wound_healing | 1.48129826 |
| 40 | MP0006082_CNS_inflammation | 1.47084736 |
| 41 | MP0010307_abnormal_tumor_latency | 1.47011964 |
| 42 | MP0000767_abnormal_smooth_muscle | 1.46798855 |
| 43 | MP0004883_abnormal_blood_vessel | 1.46686058 |
| 44 | MP0003183_abnormal_peptide_metabolism | 1.45992466 |
| 45 | MP0004947_skin_inflammation | 1.45438238 |
| 46 | MP0003763_abnormal_thymus_physiology | 1.44348961 |
| 47 | MP0003091_abnormal_cell_migration | 1.43117823 |
| 48 | MP0010368_abnormal_lymphatic_system | 1.41202180 |
| 49 | MP0005671_abnormal_response_to | 1.37362434 |
| 50 | MP0005025_abnormal_response_to | 1.37146981 |
| 51 | MP0004185_abnormal_adipocyte_glucose | 1.37083382 |
| 52 | MP0002006_tumorigenesis | 1.36876547 |
| 53 | MP0001851_eye_inflammation | 1.36830948 |
| 54 | MP0001853_heart_inflammation | 1.36333720 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.36120320 |
| 56 | * MP0000689_abnormal_spleen_morphology | 1.35473874 |
| 57 | * MP0000716_abnormal_immune_system | 1.32530014 |
| 58 | MP0003448_altered_tumor_morphology | 1.31179467 |
| 59 | MP0001879_abnormal_lymphatic_vessel | 1.31164361 |
| 60 | MP0001958_emphysema | 1.28902135 |
| 61 | MP0010155_abnormal_intestine_physiology | 1.27883962 |
| 62 | * MP0002722_abnormal_immune_system | 1.27267528 |
| 63 | MP0002933_joint_inflammation | 1.26930869 |
| 64 | MP0009785_altered_susceptibility_to | 1.26634009 |
| 65 | MP0005164_abnormal_response_to | 1.23760787 |
| 66 | MP0003866_abnormal_defecation | 1.21856666 |
| 67 | MP0008469_abnormal_protein_level | 1.21020675 |
| 68 | MP0009333_abnormal_splenocyte_physiolog | 1.20957532 |
| 69 | MP0006054_spinal_hemorrhage | 1.20097564 |
| 70 | MP0003075_altered_response_to | 1.18063588 |
| 71 | MP0000465_gastrointestinal_hemorrhage | 1.17799295 |
| 72 | MP0004084_abnormal_cardiac_muscle | 1.17789621 |
| 73 | * MP0002429_abnormal_blood_cell | 1.17395032 |
| 74 | MP0000733_abnormal_muscle_development | 1.16254097 |
| 75 | * MP0000703_abnormal_thymus_morphology | 1.13963265 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 1.13604929 |
| 77 | MP0002998_abnormal_bone_remodeling | 1.11996309 |
| 78 | MP0001845_abnormal_inflammatory_respons | 1.10846608 |
| 79 | MP0000858_altered_metastatic_potential | 1.07002642 |
| 80 | * MP0010630_abnormal_cardiac_muscle | 1.06075128 |
| 81 | MP0009764_decreased_sensitivity_to | 1.04897617 |
| 82 | MP0002148_abnormal_hypersensitivity_rea | 1.04863669 |
| 83 | MP0010234_abnormal_vibrissa_follicle | 1.02964385 |
| 84 | MP0005310_abnormal_salivary_gland | 1.01210590 |
| 85 | MP0000343_altered_response_to | 1.00724842 |
| 86 | MP0003690_abnormal_glial_cell | 0.99776292 |
| 87 | MP0002254_reproductive_system_inflammat | 0.97614590 |
| 88 | MP0002009_preneoplasia | 0.95939418 |
| 89 | MP0003045_fibrosis | 0.95774179 |
| 90 | * MP0002925_abnormal_cardiovascular_devel | 0.92003069 |
| 91 | MP0001915_intracranial_hemorrhage | 0.90750864 |
| 92 | MP0001849_ear_inflammation | 0.90035231 |
| 93 | MP0003724_increased_susceptibility_to | 0.89708505 |
| 94 | MP0008004_abnormal_stomach_pH | 0.89619662 |
| 95 | MP0003172_abnormal_lysosome_physiology | 0.89470572 |
| 96 | MP0002877_abnormal_melanocyte_morpholog | 0.89253685 |
| 97 | MP0000604_amyloidosis | 0.89149432 |
| 98 | MP0004272_abnormal_basement_membrane | 0.88696973 |
| 99 | MP0005409_darkened_coat_color | 0.87339762 |
| 100 | MP0009840_abnormal_foam_cell | 0.87065029 |
| 101 | MP0005166_decreased_susceptibility_to | 0.86927262 |
| 102 | MP0003453_abnormal_keratinocyte_physiol | 0.85422144 |
| 103 | MP0000569_abnormal_digit_pigmentation | 0.85229766 |
| 104 | MP0002088_abnormal_embryonic_growth/wei | 0.84727224 |
| 105 | MP0000015_abnormal_ear_pigmentation | 0.84235396 |
| 106 | MP0000249_abnormal_blood_vessel | 0.84038348 |
| 107 | * MP0002086_abnormal_extraembryonic_tissu | 0.83945352 |
| 108 | MP0003077_abnormal_cell_cycle | 0.83691958 |
| 109 | MP0003567_abnormal_fetal_cardiomyocyte | 0.83614197 |
| 110 | MP0003984_embryonic_growth_retardation | 0.83485492 |
| 111 | MP0005666_abnormal_adipose_tissue | 0.82228010 |
| 112 | MP0000490_abnormal_crypts_of | 0.81090050 |
| 113 | MP0005390_skeleton_phenotype | 0.80871493 |
| 114 | MP0002128_abnormal_blood_circulation | 0.80815618 |
| 115 | MP0004130_abnormal_muscle_cell | 0.80586196 |
| 116 | MP0002138_abnormal_hepatobiliary_system | 0.80378020 |
| 117 | MP0008007_abnormal_cellular_replicative | 0.79991104 |
| 118 | MP0003795_abnormal_bone_structure | 0.78149834 |
| 119 | MP0005275_abnormal_skin_tensile | 0.77466464 |
| 120 | MP0002928_abnormal_bile_duct | 0.76993799 |
| 121 | MP0002332_abnormal_exercise_endurance | 0.74858581 |
| 122 | MP0009763_increased_sensitivity_to | 0.72735172 |
| 123 | MP0001663_abnormal_digestive_system | 0.65279923 |
| 124 | MP0002133_abnormal_respiratory_system | 0.64076378 |
| 125 | MP0005388_respiratory_system_phenotype | 0.64076378 |
| 126 | MP0003656_abnormal_erythrocyte_physiolo | 0.63935925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cerebral aneurysm (HP:0004944) | 4.03653244 |
| 2 | Hematochezia (HP:0002573) | 3.93586702 |
| 3 | Gastrointestinal infarctions (HP:0005244) | 3.49415549 |
| 4 | Stomatitis (HP:0010280) | 3.47639809 |
| 5 | Recurrent skin infections (HP:0001581) | 3.37262349 |
| 6 | Meningitis (HP:0001287) | 3.21854529 |
| 7 | Spontaneous hematomas (HP:0007420) | 3.21386566 |
| 8 | Chronic obstructive pulmonary disease (HP:0006510) | 3.21207086 |
| 9 | Obstructive lung disease (HP:0006536) | 3.21207086 |
| 10 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.16065433 |
| 11 | Recurrent cutaneous fungal infections (HP:0011370) | 3.16065433 |
| 12 | Increased IgE level (HP:0003212) | 3.08042205 |
| 13 | Eczematoid dermatitis (HP:0000976) | 3.06861763 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.06400180 |
| 15 | Aortic aneurysm (HP:0004942) | 3.00185228 |
| 16 | Keratoconjunctivitis sicca (HP:0001097) | 2.89027221 |
| 17 | Abnormality of the fingertips (HP:0001211) | 2.81348212 |
| 18 | Vasculitis (HP:0002633) | 2.77703534 |
| 19 | Urticaria (HP:0001025) | 2.75754410 |
| 20 | Myositis (HP:0100614) | 2.75129211 |
| 21 | Encephalitis (HP:0002383) | 2.71076877 |
| 22 | Hemoptysis (HP:0002105) | 2.67520533 |
| 23 | Epistaxis (HP:0000421) | 2.66722863 |
| 24 | Cellulitis (HP:0100658) | 2.65947805 |
| 25 | Gingival bleeding (HP:0000225) | 2.63442320 |
| 26 | Osteolytic defects of the hand bones (HP:0009699) | 2.61326270 |
| 27 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.61326270 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 2.58199171 |
| 29 | Aortic dissection (HP:0002647) | 2.57623116 |
| 30 | Keratoconjunctivitis (HP:0001096) | 2.57519965 |
| 31 | Protrusio acetabuli (HP:0003179) | 2.53764282 |
| 32 | Amyloidosis (HP:0011034) | 2.52940836 |
| 33 | Pulmonary embolism (HP:0002204) | 2.49734730 |
| 34 | Increased density of long bones (HP:0006392) | 2.48730593 |
| 35 | Mitral valve prolapse (HP:0001634) | 2.47987200 |
| 36 | Pulmonary infiltrates (HP:0002113) | 2.46657726 |
| 37 | Thrombocytosis (HP:0001894) | 2.46605486 |
| 38 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.43880071 |
| 39 | Striae distensae (HP:0001065) | 2.43495804 |
| 40 | Premature rupture of membranes (HP:0001788) | 2.39718418 |
| 41 | Spondylolisthesis (HP:0003302) | 2.36393453 |
| 42 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.36108897 |
| 43 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.36108897 |
| 44 | Abnormality of glycolipid metabolism (HP:0010969) | 2.36108897 |
| 45 | Bicuspid aortic valve (HP:0001647) | 2.34809205 |
| 46 | Hypochromic microcytic anemia (HP:0004840) | 2.33620832 |
| 47 | Episodic fever (HP:0001954) | 2.32139985 |
| 48 | Recurrent viral infections (HP:0004429) | 2.30584881 |
| 49 | Arterial thrombosis (HP:0004420) | 2.30460528 |
| 50 | Hypochromic anemia (HP:0001931) | 2.28114569 |
| 51 | Myocardial infarction (HP:0001658) | 2.26885205 |
| 52 | Recurrent fungal infections (HP:0002841) | 2.25966948 |
| 53 | Colitis (HP:0002583) | 2.24605009 |
| 54 | Systemic lupus erythematosus (HP:0002725) | 2.24598652 |
| 55 | Anorexia (HP:0002039) | 2.23334476 |
| 56 | Increased connective tissue (HP:0009025) | 2.21707548 |
| 57 | Orchitis (HP:0100796) | 2.20655272 |
| 58 | Dilatation of the ascending aorta (HP:0005111) | 2.20643848 |
| 59 | Abnormality of the nasal mucosa (HP:0000433) | 2.20445618 |
| 60 | Panhypogammaglobulinemia (HP:0003139) | 2.20008527 |
| 61 | Ankle contracture (HP:0006466) | 2.18331833 |
| 62 | Loss of speech (HP:0002371) | 2.17513562 |
| 63 | Interstitial pulmonary disease (HP:0006530) | 2.16796367 |
| 64 | Persistence of primary teeth (HP:0006335) | 2.15626177 |
| 65 | Petechiae (HP:0000967) | 2.14124936 |
| 66 | Aneurysm (HP:0002617) | 2.13007777 |
| 67 | Abnormal platelet volume (HP:0011876) | 2.12782892 |
| 68 | Spinal cord lesions (HP:0100561) | 2.12720065 |
| 69 | Syringomyelia (HP:0003396) | 2.12720065 |
| 70 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.12433376 |
| 71 | Chronic otitis media (HP:0000389) | 2.12334094 |
| 72 | Shallow orbits (HP:0000586) | 2.12059141 |
| 73 | Asymmetric septal hypertrophy (HP:0001670) | 2.10487535 |
| 74 | Peritonitis (HP:0002586) | 2.10481555 |
| 75 | Gastrointestinal inflammation (HP:0004386) | 2.10102941 |
| 76 | Granulocytopenia (HP:0001913) | 2.10057830 |
| 77 | Inflammation of the large intestine (HP:0002037) | 2.09506673 |
| 78 | Absent frontal sinuses (HP:0002688) | 2.09258176 |
| 79 | Microcytic anemia (HP:0001935) | 2.07761044 |
| 80 | Purpura (HP:0000979) | 2.07645847 |
| 81 | Slow saccadic eye movements (HP:0000514) | 2.05937771 |
| 82 | Arterial tortuosity (HP:0005116) | 2.02347377 |
| 83 | Abnormality of T cells (HP:0002843) | 2.00608325 |
| 84 | Polycythemia (HP:0001901) | 1.99236766 |
| 85 | Cervical subluxation (HP:0003308) | 1.98874789 |
| 86 | Viral hepatitis (HP:0006562) | 1.98729556 |
| 87 | Ulnar bowing (HP:0003031) | 1.98642787 |
| 88 | Increased cerebral lipofuscin (HP:0011813) | 1.98110215 |
| 89 | Rectal prolapse (HP:0002035) | 1.97938239 |
| 90 | Periodontitis (HP:0000704) | 1.94589763 |
| 91 | Abnormality of the endocardium (HP:0004306) | 1.93714723 |
| 92 | Increased mean platelet volume (HP:0011877) | 1.90511019 |
| 93 | Abnormality of macrophages (HP:0004311) | 1.90098455 |
| 94 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.89118979 |
| 95 | IgM deficiency (HP:0002850) | 1.88793258 |
| 96 | Sepsis (HP:0100806) | 1.88331565 |
| 97 | Polygenic inheritance (HP:0010982) | 1.87254678 |
| 98 | Papilloma (HP:0012740) | 1.87067778 |
| 99 | Verrucae (HP:0200043) | 1.87067778 |
| 100 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.86057855 |
| 101 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.86057855 |
| 102 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.86057855 |
| 103 | Glomerulopathy (HP:0100820) | 1.85183284 |
| 104 | Hyperacusis (HP:0010780) | 1.84859536 |
| 105 | Chest pain (HP:0100749) | 1.84520907 |
| 106 | Hypergammaglobulinemia (HP:0010702) | 1.84335884 |
| 107 | Vascular tortuosity (HP:0004948) | 1.83508945 |
| 108 | High pitched voice (HP:0001620) | 1.82055840 |
| 109 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.80760003 |
| 110 | Mucopolysacchariduria (HP:0008155) | 1.80760003 |
| 111 | Abnormality of the pleura (HP:0002103) | 1.80732280 |
| 112 | Disproportionate tall stature (HP:0001519) | 1.80553445 |
| 113 | Autoimmune thrombocytopenia (HP:0001973) | 1.80326418 |
| 114 | Entropion (HP:0000621) | 1.78638834 |
| 115 | Increased variability in muscle fiber diameter (HP:0003557) | 1.78440436 |
| 116 | Abnormality of the peritoneum (HP:0002585) | 1.78274153 |
| 117 | Skin ulcer (HP:0200042) | 1.78067354 |
| 118 | Lymphopenia (HP:0001888) | 1.77377143 |
| 119 | Fatigue (HP:0012378) | 1.77039304 |
| 120 | Pustule (HP:0200039) | 1.76808881 |
| 121 | Broad metatarsal (HP:0001783) | 1.76687650 |
| 122 | Nasal polyposis (HP:0100582) | 1.76543369 |
| 123 | Emphysema (HP:0002097) | 1.75996353 |
| 124 | Spinal muscular atrophy (HP:0007269) | 1.75697003 |
| 125 | Hepatosplenomegaly (HP:0001433) | 1.74880734 |
| 126 | Dysostosis multiplex (HP:0000943) | 1.74185010 |
| 127 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.73756446 |
| 128 | Restrictive lung disease (HP:0002091) | 1.73599913 |
| 129 | T lymphocytopenia (HP:0005403) | 1.73489478 |
| 130 | Mediastinal lymphadenopathy (HP:0100721) | 1.73482459 |
| 131 | Agammaglobulinemia (HP:0004432) | 1.73122568 |
| 132 | Recurrent bronchitis (HP:0002837) | 1.73065486 |
| 133 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.71530760 |
| 134 | Short 4th metacarpal (HP:0010044) | 1.71530760 |
| 135 | Osteomyelitis (HP:0002754) | 1.71458542 |
| 136 | Frequent falls (HP:0002359) | 1.71402860 |
| 137 | Long eyelashes (HP:0000527) | 1.70924867 |
| 138 | Enlarged penis (HP:0000040) | 1.70865733 |
| 139 | Subacute progressive viral hepatitis (HP:0006572) | 1.69966264 |
| 140 | Mucosal telangiectasiae (HP:0100579) | 1.68854977 |
| 141 | Asymmetry of the thorax (HP:0001555) | 1.67836992 |
| 142 | Radial bowing (HP:0002986) | 1.66950826 |
| 143 | Coarse hair (HP:0002208) | 1.66402569 |
| 144 | Abnormality of T cell number (HP:0011839) | 1.66030117 |
| 145 | Abnormality of the lumbar spine (HP:0100712) | 1.64742504 |
| 146 | Thoracic kyphosis (HP:0002942) | 1.64523651 |
| 147 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.64491360 |
| 148 | Optic neuritis (HP:0100653) | 1.63102976 |
| 149 | Retrobulbar optic neuritis (HP:0100654) | 1.63102976 |
| 150 | Conjunctival telangiectasia (HP:0000524) | 1.61486043 |
| 151 | Camptodactyly of toe (HP:0001836) | 1.60457090 |
| 152 | Esophageal varix (HP:0002040) | 1.59714108 |
| 153 | Gingivitis (HP:0000230) | 1.59405105 |
| 154 | Prolonged bleeding time (HP:0003010) | 1.58919033 |
| 155 | Leukocytosis (HP:0001974) | 1.57259060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.93102004 |
| 2 | MAP4K1 | 3.18539900 |
| 3 | PKN2 | 3.17514756 |
| 4 | PRPF4B | 3.12829745 |
| 5 | EEF2K | 3.10573059 |
| 6 | TTN | 3.06382896 |
| 7 | TGFBR2 | 3.01735541 |
| 8 | ERN1 | 2.37210829 |
| 9 | MAP3K10 | 2.28574486 |
| 10 | FES | 2.26421394 |
| 11 | STK10 | 2.20989417 |
| 12 | CDK12 | 2.14929531 |
| 13 | TYK2 | 2.02742371 |
| 14 | KIT | 2.00078443 |
| 15 | JAK3 | 1.80178651 |
| 16 | TNK2 | 1.78218086 |
| 17 | CSF1R | 1.75504371 |
| 18 | PTK6 | 1.66062603 |
| 19 | LRRK2 | 1.58231673 |
| 20 | FGFR3 | 1.55772801 |
| 21 | TIE1 | 1.53846481 |
| 22 | ZAP70 | 1.50308880 |
| 23 | FGR | 1.48935875 |
| 24 | SMG1 | 1.47200676 |
| 25 | MAP3K14 | 1.46866904 |
| 26 | RIPK1 | 1.45789170 |
| 27 | ITK | 1.44179888 |
| 28 | EPHB1 | 1.43540189 |
| 29 | MAP3K1 | 1.41674408 |
| 30 | TAOK1 | 1.41271391 |
| 31 | TBK1 | 1.40893730 |
| 32 | FLT3 | 1.39013781 |
| 33 | FGFR4 | 1.36680908 |
| 34 | CAMK1D | 1.35406743 |
| 35 | MAP3K11 | 1.34810028 |
| 36 | RPS6KA4 | 1.31906229 |
| 37 | JAK1 | 1.31743923 |
| 38 | BTK | 1.29611860 |
| 39 | PAK4 | 1.29221696 |
| 40 | KSR2 | 1.25689841 |
| 41 | MARK2 | 1.25546770 |
| 42 | TRPM7 | 1.23966440 |
| 43 | HCK | 1.22881433 |
| 44 | CSK | 1.20454072 |
| 45 | GRK6 | 1.19223212 |
| 46 | TGFBR1 | 1.15792180 |
| 47 | NEK2 | 1.11251523 |
| 48 | KDR | 1.10852961 |
| 49 | SIK3 | 1.10804439 |
| 50 | MAP3K6 | 1.08254863 |
| 51 | BLK | 1.06078507 |
| 52 | IKBKB | 1.05543200 |
| 53 | SIK1 | 1.04849578 |
| 54 | CDK4 | 1.01671456 |
| 55 | CDK6 | 0.99798299 |
| 56 | YES1 | 0.98380132 |
| 57 | PIM1 | 0.98292476 |
| 58 | CDC42BPA | 0.98244951 |
| 59 | PDPK1 | 0.97953168 |
| 60 | IRAK1 | 0.97208557 |
| 61 | TAOK3 | 0.96243003 |
| 62 | MARK3 | 0.93803214 |
| 63 | IRAK2 | 0.92383703 |
| 64 | TEC | 0.92340843 |
| 65 | TAOK2 | 0.91332112 |
| 66 | DMPK | 0.90557078 |
| 67 | PRKCH | 0.90021966 |
| 68 | PDGFRA | 0.89984352 |
| 69 | CAMK1G | 0.89290324 |
| 70 | CHUK | 0.88934988 |
| 71 | MAPK7 | 0.86426374 |
| 72 | NEK9 | 0.86413476 |
| 73 | STK4 | 0.84222035 |
| 74 | MTOR | 0.83914001 |
| 75 | MAP3K8 | 0.82480978 |
| 76 | IKBKE | 0.81345958 |
| 77 | LCK | 0.80960667 |
| 78 | STK3 | 0.79735572 |
| 79 | ICK | 0.79727525 |
| 80 | JAK2 | 0.79450797 |
| 81 | RPS6KB2 | 0.78210286 |
| 82 | SCYL2 | 0.77807251 |
| 83 | BRD4 | 0.76692629 |
| 84 | PAK2 | 0.76133882 |
| 85 | SYK | 0.75930132 |
| 86 | HIPK2 | 0.75629600 |
| 87 | IRAK4 | 0.74128646 |
| 88 | SIK2 | 0.72109085 |
| 89 | CLK1 | 0.70541287 |
| 90 | PRKD2 | 0.69877179 |
| 91 | PDGFRB | 0.69771655 |
| 92 | PIK3CG | 0.67837142 |
| 93 | ALK | 0.67444983 |
| 94 | TXK | 0.66262271 |
| 95 | STK38 | 0.65559593 |
| 96 | MELK | 0.60259545 |
| 97 | CDK9 | 0.59085984 |
| 98 | MAP3K2 | 0.58710234 |
| 99 | DYRK1B | 0.57773649 |
| 100 | MAPKAPK3 | 0.57768725 |
| 101 | MATK | 0.57652191 |
| 102 | MAP3K7 | 0.57075775 |
| 103 | RIPK4 | 0.56604585 |
| 104 | RPS6KA2 | 0.55612629 |
| 105 | MAP3K13 | 0.53917150 |
| 106 | FYN | 0.53473254 |
| 107 | EPHA3 | 0.53354298 |
| 108 | PTK2 | 0.52679863 |
| 109 | * MAP2K3 | 0.52597048 |
| 110 | NLK | 0.51615889 |
| 111 | PRKAA2 | 0.50942279 |
| 112 | BMX | 0.48583911 |
| 113 | RPS6KA6 | 0.47672085 |
| 114 | LATS1 | 0.46644818 |
| 115 | EGFR | 0.46461013 |
| 116 | PRKD1 | 0.44591988 |
| 117 | TSSK6 | 0.44521769 |
| 118 | ILK | 0.43716049 |
| 119 | BMPR2 | 0.43594394 |
| 120 | CAMKK1 | 0.43294798 |
| 121 | PDK1 | 0.43163774 |
| 122 | RPS6KL1 | 0.42550695 |
| 123 | RPS6KC1 | 0.42550695 |
| 124 | MAPKAPK2 | 0.41113604 |
| 125 | MOS | 0.41020523 |
| 126 | FGFR1 | 0.40698677 |
| 127 | PRKG2 | 0.40295773 |
| 128 | MAP3K5 | 0.39656801 |
| 129 | STK11 | 0.38522118 |
| 130 | LYN | 0.37879972 |
| 131 | PASK | 0.37789340 |
| 132 | IRAK3 | 0.37741937 |
| 133 | PTK2B | 0.36608267 |
| 134 | MAPK12 | 0.34429182 |
| 135 | MAPK11 | 0.33916526 |
| 136 | RET | 0.33708000 |
| 137 | ABL1 | 0.33397673 |
| 138 | STK24 | 0.33319940 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.30179636 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.25253675 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.20647731 |
| 4 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.93492276 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.78855982 |
| 6 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.75216382 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.74382448 |
| 8 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.72909591 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 1.70942081 |
| 10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.69850745 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.69514849 |
| 12 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.65622285 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.59258143 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.59244580 |
| 15 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.56366547 |
| 16 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.55173218 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.54706256 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.51512693 |
| 19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.48545078 |
| 20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.47939231 |
| 21 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.47115890 |
| 22 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.44258373 |
| 23 | Shigellosis_Homo sapiens_hsa05131 | 1.43920285 |
| 24 | Platelet activation_Homo sapiens_hsa04611 | 1.43385401 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.43172925 |
| 26 | Focal adhesion_Homo sapiens_hsa04510 | 1.42704998 |
| 27 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.39269083 |
| 28 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.35693557 |
| 29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.34439202 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 1.34088160 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 1.31205426 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.26535001 |
| 33 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.25178611 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24302495 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.23996874 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.22624159 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.20595136 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19840760 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.18481850 |
| 40 | Phagosome_Homo sapiens_hsa04145 | 1.18060757 |
| 41 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.17929350 |
| 42 | Insulin resistance_Homo sapiens_hsa04931 | 1.17234615 |
| 43 | Adherens junction_Homo sapiens_hsa04520 | 1.17157456 |
| 44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.17038717 |
| 45 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.15872930 |
| 46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.14325493 |
| 47 | Tuberculosis_Homo sapiens_hsa05152 | 1.14184965 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 1.14182899 |
| 49 | Pertussis_Homo sapiens_hsa05133 | 1.12027548 |
| 50 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.11779693 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.10746305 |
| 52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.10566694 |
| 53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.10393899 |
| 54 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.09319764 |
| 55 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.08939615 |
| 56 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.06802802 |
| 57 | * HTLV-I infection_Homo sapiens_hsa05166 | 1.06548126 |
| 58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.04391173 |
| 59 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.03685938 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 1.01355002 |
| 61 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.99962036 |
| 62 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.99728384 |
| 63 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.99093800 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.99067400 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.95645440 |
| 66 | Malaria_Homo sapiens_hsa05144 | 0.94852824 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.94687381 |
| 68 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.93131532 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89014105 |
| 70 | Salmonella infection_Homo sapiens_hsa05132 | 0.87331971 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.87290729 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.87133373 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.85805248 |
| 74 | Colorectal cancer_Homo sapiens_hsa05210 | 0.85484577 |
| 75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.85108455 |
| 76 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.84987187 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.84448199 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84326658 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.84114976 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.82496343 |
| 81 | Lysine degradation_Homo sapiens_hsa00310 | 0.80851993 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.80555292 |
| 83 | Prostate cancer_Homo sapiens_hsa05215 | 0.77542045 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77460283 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77403481 |
| 86 | Asthma_Homo sapiens_hsa05310 | 0.77012000 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.75323134 |
| 88 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 0.74925896 |
| 89 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.74129301 |
| 90 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.73726857 |
| 91 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73520935 |
| 92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.73088680 |
| 93 | Pathways in cancer_Homo sapiens_hsa05200 | 0.72632868 |
| 94 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.72540387 |
| 95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.71536517 |
| 96 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.68909084 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68774170 |
| 98 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.68390380 |
| 99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.68348416 |
| 100 | Cell cycle_Homo sapiens_hsa04110 | 0.67454256 |
| 101 | Glioma_Homo sapiens_hsa05214 | 0.64906211 |
| 102 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.64071375 |
| 103 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.63480020 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62788564 |
| 105 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62427739 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61556206 |
| 107 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59046699 |
| 108 | Bladder cancer_Homo sapiens_hsa05219 | 0.58833056 |
| 109 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58452279 |
| 110 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.58332949 |
| 111 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58279930 |
| 112 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56746207 |
| 113 | Endocytosis_Homo sapiens_hsa04144 | 0.56625128 |
| 114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55175590 |
| 115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54830627 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53405172 |
| 117 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53283078 |
| 118 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.53158319 |
| 119 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53116099 |
| 120 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.51938972 |

